GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData

The market for GLP-1 receptor agonists is growing at an “unprecedented” rate and by 2033 will be worth more than $125 billion, according to a Friday report from analytics firm GlobalData.

GLP-1 analogs will become a dominant force in the metabolic disease space in 10 years, as the global rates of obesity and diabetes continue to grow at a rapid pace, the firm forecasts.